Suppr超能文献

高密度脂蛋白是血浆F2-异前列腺素的主要脂蛋白载体。

HDL is the major lipoprotein carrier of plasma F2-isoprostanes.

作者信息

Proudfoot Julie M, Barden Anne E, Loke Wai Mun, Croft Kevin D, Puddey Ian B, Mori Trevor A

机构信息

School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, Perth WA 6847, Australia.

出版信息

J Lipid Res. 2009 Apr;50(4):716-22. doi: 10.1194/jlr.M800607-JLR200. Epub 2008 Dec 2.

Abstract

Enhanced oxidative stress is implicated in the development of atherosclerosis in humans and animal models. F(2)-isoprostanes are formed in vivo via free radical peroxidation of arachidonic acid, and their quantification has allowed assessment of oxidative stress in vivo. F(2)-isoprostanes associate with lipids, although their distribution in human plasma lipoproteins is unknown. Our aim was to determine the distribution and levels of F(2)-isoprostanes in lipoproteins isolated from human plasma by ultracentrifugation and fast protein liquid chromatography (FPLC). F(2)-isoprostanes were significantly higher in HDL compared with LDL or VLDL after isolation by ultracentrifugation or FPLC. Furthermore, HDL3 particles contained elevated levels of F(2)-isoprostanes compared with HDL2. Platelet activating factor acetylhydrolase (PAF-AH), which hydrolyses esterified F(2)-isoprostanes from phospholipids, was predominantly associated with LDL. Reduced F(2)-isoprostanes in LDL may be related to higher PAF-AH activity in LDL. Paraoxonase 1 (PON-1) activity was associated with HDL2 and may be a contributing factor to the lower F(2)-isoprostanes in HDL2 compared with HDL3. Further studies are required to establish the implications of these findings on HDL function.

摘要

氧化应激增强与人类和动物模型动脉粥样硬化的发展有关。F(2)-异前列腺素是体内花生四烯酸通过自由基过氧化作用形成的,对其定量可用于评估体内氧化应激。F(2)-异前列腺素与脂质相关,但其在人血浆脂蛋白中的分布尚不清楚。我们的目的是通过超速离心和快速蛋白质液相色谱法(FPLC)来确定从人血浆中分离出的脂蛋白中F(2)-异前列腺素的分布和水平。通过超速离心或FPLC分离后,HDL中的F(2)-异前列腺素明显高于LDL或VLDL。此外,与HDL2相比,HDL3颗粒中F(2)-异前列腺素水平升高。血小板活化因子乙酰水解酶(PAF-AH)可从磷脂中水解酯化的F(2)-异前列腺素,它主要与LDL相关。LDL中F(2)-异前列腺素减少可能与LDL中较高的PAF-AH活性有关。对氧磷酶1(PON-1)活性与HDL2相关,可能是HDL2中F(2)-异前列腺素低于HDL3的一个促成因素 。需要进一步研究来确定这些发现对HDL功能的影响。

相似文献

1
HDL is the major lipoprotein carrier of plasma F2-isoprostanes.
J Lipid Res. 2009 Apr;50(4):716-22. doi: 10.1194/jlr.M800607-JLR200. Epub 2008 Dec 2.
4
HDL, lipid peroxidation, and atherosclerosis.
J Lipid Res. 2009 Apr;50(4):599-601. doi: 10.1194/jlr.E900001-JLR200. Epub 2009 Jan 12.
5
Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
J Lipid Res. 2003 May;44(5):927-34. doi: 10.1194/jlr.M200452-JLR200. Epub 2003 Mar 1.
6
Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):526-33. doi: 10.1161/01.ATV.0000118276.87061.00. Epub 2004 Jan 22.
8
Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.
Br J Clin Pharmacol. 2007 Jun;63(6):672-9. doi: 10.1111/j.1365-2125.2006.02832.x. Epub 2007 Jan 3.
9
Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
Prostaglandins Leukot Essent Fatty Acids. 2004 May;70(5):475-8. doi: 10.1016/j.plefa.2003.10.001.
10
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
J Lipid Res. 2003 Oct;44(10):1919-26. doi: 10.1194/jlr.M300129-JLR200. Epub 2003 Jul 16.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
3
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia.
Eur J Med Res. 2025 Apr 11;30(1):266. doi: 10.1186/s40001-025-02439-0.
4
High-density lipoprotein cholesterol: how studying the 'good cholesterol' could improve cardiovascular health.
Open Biol. 2025 Feb;15(2):240372. doi: 10.1098/rsob.240372. Epub 2025 Feb 19.
7
Oxidative modification of HDL by lipid aldehydes impacts HDL function.
Arch Biochem Biophys. 2022 Nov 15;730:109397. doi: 10.1016/j.abb.2022.109397. Epub 2022 Sep 15.
8
Oxidative Stress and Menopausal Status: The Coronary Artery Risk Development in Young Adults Cohort Study.
J Womens Health (Larchmt). 2022 Jul;31(7):1057-1065. doi: 10.1089/jwh.2021.0248. Epub 2022 Jun 8.
9
HDL Composition, Heart Failure, and Its Comorbidities.
Front Cardiovasc Med. 2022 Mar 8;9:846990. doi: 10.3389/fcvm.2022.846990. eCollection 2022.
10
High density lipoproteins and oxidative stress in breast cancer.
Lipids Health Dis. 2021 Oct 25;20(1):143. doi: 10.1186/s12944-021-01562-1.

本文引用的文献

1
Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2).
Cardiovasc Drugs Ther. 2009 Feb;23(1):73-83. doi: 10.1007/s10557-008-6133-8. Epub 2008 Oct 24.
2
The emerging roles of PAF acetylhydrolase.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S255-9. doi: 10.1194/jlr.R800024-JLR200. Epub 2008 Oct 6.
5
Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.
Free Radic Biol Med. 2006 Dec 1;41(11):1678-83. doi: 10.1016/j.freeradbiomed.2006.09.001. Epub 2006 Sep 8.
7
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?
Circulation. 2006 May 30;113(21):2548-55. doi: 10.1161/CIRCULATIONAHA.104.475715.
8
Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate.
Clin Chem. 2006 Mar;52(3):453-7. doi: 10.1373/clinchem.2005.063412. Epub 2006 Jan 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验